Salarius Pharmaceuticals Inc (SLRX) stock news · $4.9M cap
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
This SLRX news page leads with what Salarius Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for SLRX yet. We will not pad this page with generic market recap.
Latest reported SLRX revenue for 2026-06-30 was $227.6K. Net income was -$2.4M. SLRX currently screens at market cap $4.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SLRX stock page; for the tape open the quote page.
SLRX stock news FAQ
What are SLRX's latest revenue and net income?
Latest cached Salarius Pharmaceuticals Inc (SLRX) revenue for Jun 30, 2026 was $227.6K. Net income was -$2.4M. Statements: https://lician.com/financials/slrx
What is SLRX's market cap?
Salarius Pharmaceuticals Inc (SLRX) market cap is $4.9M on the latest cached fundamentals snapshot.
What kind of company is SLRX?
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Where is SLRX stock news listed?
Cached stock news for Salarius Pharmaceuticals Inc (SLRX) is listed at https://lician.com/news/slrx. Filings: https://lician.com/sec/slrx
Not investment advice.